Anika Therapeutics, Inc. (ANIK) › EPS (Diluted)Anika Therapeutics, Inc. (ANIK) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2009: $0.322010: $0.322011: $0.622012: $0.822013: $1.392014: $2.512015: $2.012016: $2.152017: $2.112018: $1.272019: $1.892020: $-1.692021: $0.282022: $-1.022023: $-5.642024: $-3.832025: $-0.76$-0.762009EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.76+80.2%2024$-3.83+32.1%2023$-5.64-452.9%2022$-1.02-464.3%2021$0.28+116.6%2020$-1.69-189.4%2019$1.89+48.8%2018$1.27-39.8%2017$2.11-1.9%2016$2.15+7.0%2015$2.01-19.9%2014$2.51+80.6%2013$1.39+69.5%2012$0.82+32.3%2011$0.62+93.8%2010$0.32+0.0%2009$0.32—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share